A combined bottom-up/top-down approach to prepare a sterile injectable nanosuspension

International Journal of Pharmaceutics

Volumn 472, Issue 1-2, 2014, Pages 130-139

  Hu, Xi ^a   Chen, Xi ^a   Zhang, Ling ^a   Lin, Xia ^b   Zhang, Yu ^a   Tang, Xing ^a   Wang, Yanjiao ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Controlled crystallization; High pressure homogenization; Nanosuspension; Physical modification; Wettability

Indexed keywords

POLYMER; RIBOFLAVIN; SURFACTANT; WATER; NANOPARTICLE; SUSPENSION;

ARTICLE; BIOCOMPATIBILITY; CRYSTAL; CRYSTALLIZATION; FILTRATION; FREEZE DRYING; FREEZING; HYDROPHOBICITY; HYPERBARISM; NANOSUSPENSION; PARTICLE SIZE; PRIORITY JOURNAL; STERILE FILTRATION; SUSPENSION; WETTABILITY; ANIMAL; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRESSURE; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; THIGH;

ANIMALS; CRYSTALLIZATION; DRUG COMPOUNDING; FREEZE DRYING; INJECTIONS, INTRAMUSCULAR; MALE; MUSCLE, SKELETAL; NANOPARTICLES; PARTICLE SIZE; PRESSURE; RATS, SPRAGUE-DAWLEY; RIBOFLAVIN; SUSPENSIONS; THIGH; WETTABILITY;

EID: 84903182032     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.06.018     Document Type: Article

References (24)

1. A.M. Afanas'ev, and V.G. Kohn Dynamical theory of X-ray diffraction in crystals with defects Acta Crystallogr. A 27 1971 421 430
2. M.R. Caira, G. Bettinetti, and M. Sorrenti Structural relationships, thermal properties, and physicochemical characterization of anhydrous and solvated crystalline forms of tetroxoprim J. Pharm. Sci. 91 2002 467 481 (Pubitemid 34137368)
3. E. Celozzi, V.J. Lotti, E.O. Stapley, and A.K. Miller An animal model for assessing pain-on-injection of antibiotics J. Pharmacol. Methods 4 1980 285 289 (Pubitemid 11125772)
4. C. Chen, D. Han, C. Cai, and X. Tang An overview of liposome lyophilization and its future potential J. Control. Release 142 2010 299 311
5. S.M. D'Addio, and R.K. Prud'homme Controlling drug nanoparticle formation by rapid precipitation Adv. Drug Deliv. Rev. 63 2011 417 426
6. H. De Waard, W. Hinrichs, and H. Frijlink A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying J. Control. Release 128 2008 179 183
7. Franois, M.K.J., Dries, W.M.A.C., Basstanie, E.D.G., 2003. Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters. U.S. Patent 6,555,544[P].
8. S. Ganta, J.W. Paxton, B.C. Baguley, and S. Garg Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery Int. J. Pharm. 367 2009 179 186
9. X. Hu, X. Lin, Y. Gu, Z. Liu, Y. Tang, Y. Zhang, X. Chen, Y. Wang, and X. Tang Biocompatible riboflavin laurate long-acting injectable nanosuspensions allowing sterile filtration Drug Deliv. 2013 10.3109/10717544.2013.850760
10. C.M. Keck, and R.H. Müller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
11. J.T. Korhonen, T. Huhtamaki, O. Ikkala, and R.H. Ras Reliable measurement of the receding contact angle Langmuir 29 2013 3858 3863
12. K. Krause, O. Kayser, K. Mäder, R. Gust, and R. Müller Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation Int. J. Pharm. 196 2000 169 172 (Pubitemid 30105736)
13. J. Lee, and Y. Cheng Critical freezing rate in freeze drying nanocrystal dispersions J. Control. Release 111 2006 185 192 (Pubitemid 43290007)
14. H. Lou, L. Gao, X. Wei, Z. Zhang, D. Zheng, D. Zhang, X. Zhang, Y. Li, and Q. Zhang Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice Colloids Surf. B Biointerfaces 87 2011 319 325
15. C. Mohanty, and S.K. Sahoo The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 31 2010 6597 6611
16. Moschwitzer, J., Lemke, A., 2006. Method for the Gentle Production of Ultrafine Particle Suspensions and Ultrafine Particles and the Use Thereof. Google Patents.
17. R.S. Mulik, J. Monkkonen, R.O. Juvonen, K.R. Mahadik, and A.R. Paradkar Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis Int. J. Pharm. 398 2010 190 203
18. J. Pardeike, and R.H. Müller Nanosuspensions: a promising formulation for the new phospholipase A 2 inhibitor PX-18 Int. J. Pharm. 391 2010 322 329
19. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796 (Pubitemid 39242830)
20. M.R. Sovizi, S.S. Hajimirsadeghi, and B. Naderizadeh Effect of particle size on thermal decomposition of nitrocellulose J. Hazard. Mater. 168 2009 1134 1139
21. Y. Wang, Z. Liu, D. Zhang, X. Gao, X. Zhang, C. Duan, L. Jia, F. Feng, Y. Huang, Y. Shen, and Q. Zhang Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension Colloids Surf. B Biointerfaces 83 2011 189 197
22. L. Wu, J. Zhang, and W. Watanabe Physical and chemical stability of drug nanoparticles Adv. Drug Deliv. Rev. 63 2011 456 469
23. R. Xiong, W. Lu, J. Li, P. Wang, R. Xu, and T. Chen Preparation and characterization of intravenously injectable nimodipine nanosuspension Int. J. Pharm. 350 2008 338 343
24. M.M. Yallapu, M.R. Dobberpuhl, D.M. Maher, M. Jaggi, and S.C. Chauhan Design of curcumin loaded cellulose nanoparticles for prostate Curr. Drug Metab. 13 2012 120 128